Jim Petrik
Overview
Explore the profile of Jim Petrik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delfinis L, Khajehzadehshoushtar S, Flewwelling L, Andrews N, Garibotti M, Gandhi S, et al.
bioRxiv
. 2024 Nov;
PMID: 39484418
Cancer cachexia, and the related loss of muscle and strength, worsens quality of life and lowers overall survival. Recently, a novel 'pre-atrophy' muscle weakness was identified during early-stage cancer. While...
2.
Osz K, Ross M, Petrik J
Reprod Biol Endocrinol
. 2024 Sep;
22(1):114.
PMID: 39223614
No abstract available.
3.
Ram A, Matuszewska K, McKenna C, Petrik J, Oblak M
Front Vet Sci
. 2024 Aug;
11:1392504.
PMID: 39144083
Significance: Many commercially available near-infrared (NIR) fluorescence imaging systems lack algorithms for real-time quantifiable fluorescence data. Creation of a workflow for clinical assessment and analysis may provide clinical researchers with...
4.
Garlisi B, Lauks S, Aitken C, Ogilvie L, Lockington C, Petrik D, et al.
Curr Oncol
. 2024 Jul;
31(7):3826-3844.
PMID: 39057155
The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity than previously understood. In response to aggressive pro-angiogenic stimulus, blood vessels form rapidly and are dysfunctional, resulting in...
5.
Ogilvie L, Delfinis L, Coyle-Asbil B, Vudatha V, Alshamali R, Garlisi B, et al.
Am J Pathol
. 2024 Jul;
194(10):1823-1843.
PMID: 39032600
Muscle atrophy and weakness are prevalent features of cancer. Although extensive research has characterized skeletal muscle wasting in cancer cachexia, limited studies have investigated how cardiac structure and function are...
6.
Delfinis L, Ogilvie L, Khajehzadehshoushtar S, Gandhi S, Garibotti M, Thuhan A, et al.
Mol Metab
. 2024 Jun;
86:101976.
PMID: 38925248
Objectives: A high proportion of women with advanced epithelial ovarian cancer (EOC) experience weakness and cachexia. This relationship is associated with increased morbidity and mortality. EOC is the most lethal...
7.
Eichhorn J, Petrik J
Pathol Res Pract
. 2024 May;
259:155370.
PMID: 38815507
Cancer is a significant global health issue that poses a considerable burden on both patients and healthcare systems. Many different types of cancers exist that often require unique treatment approaches...
8.
Delfinis L, Ogilvie L, Khajehzadehshoushtar S, Gandhi S, Garibotti M, Thuhan A, et al.
bioRxiv
. 2024 Apr;
PMID: 38645227
Objectives: A high proportion of women with advanced epithelial ovarian cancer (EOC) experience weakness and cachexia. This relationship is associated with increased morbidity and mortality. EOC is the most lethal...
9.
Ogilvie L, Coyle-Asbil B, Brunt K, Petrik J, Simpson J
Am J Physiol Heart Circ Physiol
. 2024 Apr;
326(6):H1515-H1537.
PMID: 38639740
Cardiovascular disease (CVD) and cancer are the leading causes of mortality worldwide. Although generally thought of as distinct diseases, the intersectional overlap between CVD and cancer is increasingly evident in...
10.
Pereira M, Glogova A, Haagsma J, Stewart J, Shepherd T, Petrik J
J Ovarian Res
. 2023 Nov;
16(1):218.
PMID: 37986175
High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of epithelial ovarian cancer, characterized by gain-of-function TP53 mutations originating in the fallopian tube epithelium. Therapeutic intervention occurs at...